Global shares
DRUG
Betashares Global Healthcare Currency Hedged ETF · Betashares
A basket of the world's largest healthcare companies — drug makers, medical-device firms and health insurers — held outside Australia.
What the fee costs you
The management fee is 0.57% a year. Here’s what that works out to in dollars:
A 0.57% yearly fee works out to about $57 a year per $10,000 invested.
A rough guide based on the headline fee only. Other costs (such as brokerage or buy/sell spreads) aren’t included.
The basics
- Issuer
- Betashares
- Asset class
- Global shares
- Number of holdings
- ~60
- Where it invests
- Global, heavily weighted to the United States, with smaller slices across Europe and Japan.
- Income paid
- Half-yearly
- Currency hedged
- Yes — It's currency-hedged back to Australian dollars, so day-to-day moves in the Australian dollar against foreign currencies are largely smoothed out, leaving mainly the markets themselves.
Its character
A single-sector fund: it owns one part of the market — healthcare — rather than the whole market, so it leans on how healthcare companies perform as a group.
What to keep in mind
Concentrated in a single sector, so it can move more sharply than a broad global fund — a narrow sector is a narrower spread of risk.
How this fund relates to others
Its large healthcare names overlap with the healthcare slice already inside broad global funds, but here that slice is the whole fund.
Figures last verified 2026-06-22against the issuer’s factsheet and PDS.